Chronobiology and chronopathophysiology of nocturnal asthma

International Journal of Clinical Practice

Volumn 51, Issue 7, 1997, Pages 455-462

  Syabbalo, N ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHOCONSTRICTING AGENT; CYTOKINE; HISTAMINE; LEUKOTRIENE; MEMBRANE METALLOENDOPEPTIDASE; NEUROHORMONE; PROSTAGLANDIN; SUPEROXIDE;

ASTHMA; BIOLOGICAL RHYTHM; BLOOD VESSEL PERMEABILITY; CHRONOBIOLOGY; CIRCADIAN RHYTHM; DISEASE SEVERITY; EDEMA; EOSINOPHIL; HUMAN; INFLAMMATION; LYMPHOCYTE; MAST CELL; MEDIATOR; MORTALITY; NEUROGENIC INFLAMMATION; NEUTROPHIL; NIGHT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYMPTOM; VAGUS TONE;

ASTHMA; CATECHOLAMINES; CIRCADIAN RHYTHM; HUMANS;

EID: 0030687637     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (115)

1. Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med 1988; 85: 6S-8S.
2. Cochrane GM, Clark TJH. A survey of asthma mortality in patients between ages 35 and 65 in the greater London hospitals in 1971. Thorax 1975; 30: 300-315.
3. Barnes PJ. New drugs for asthma. Clin Exp Allergy 1996; 26: 738-745.
4. Smolensky MH, D'Alonzo GE. Medical chronobiology: concepts and applications. In: Nocturnal Asthma: Mechanisms and Treatment. Mount Kisco, New York: Futura Publishing, 1993, 1-23.
5. More-Ede MC, Sulzman FM, Fuller CA. The Clock That Times Us. Cambridge, MA: Havard University Press, 1982.
6. Reinberg A, Smolensky MH. Biological Rhythms and Medicine. New York: Springer-Verlag, 1983.
7. Pincus DJ, Beam WR, Martin RJ. Chronobiology and chronotherapy of asthma. Clin Chest Med 1995; 16: 699-713.
8. Hetzel MR. The pulmonary clock. Thorax 1981; 36: 481-486.
9. Floyer JA. Treatise of Asthma. London: Wilkin and Inngs, 1698.
10. Salter HH. On Asthma: Its Pathology and Treatment. Philadelphia: Blanchard and Lea, 1864.
11. Dethlefsen U, Repges R. Ein neues Therapie-prinzyp beu nächtlichen Asthma. Med Klin 1985; 80: 44-47.
12. Meijer GG, Oosterhoff Y, Weersink EJM et al. Nocturnal dyspnoea: prevalence in asthmatic children. Eur Resp J 1991; 4: 523S (abstract).
13. Syabbalo NC. Seasonal and nocturnal asthma in the tropics and sub-tropics. S Afr Med J 1990; 77: 654.
14. Falconer A, Oldman C, Helms P. Poor agreement between reported and recorded nocturnal cough in asthma. Pediatr Pulmonol 1993; 15: 209-211.
15. Weersink EJM, Postma DS. Nocturnal asthma: not a separate disease entity. Resp Med 1994; 88: 483-491.
16. Martin RJ. Nocturnal asthma: an overview. In: Martin RJ, Ed. Nocturnal Asthma: Mechanisms and Treatment. New York: Futura Publishing, 1993; 71-115.
17. Hetzel MR, Clark TJH, Branthwaite MA. Asthma: analysis of sudden deaths and ventilatory arrests in hospital. BMJ 1977; 1: 808-811.
18. Douglas NJ. Asthma at night. Clin Chest Med 1985; 6: 663-674.
19. Robertson CF, Rubinfield AR, Bowes G. Deaths from asthma in Victoria: a 12-month survey. Med J Aust 1990; 152: 511-517.
20. Jarjour NN, Busse WW. Understanding and identifying nocturnal asthma. J Resp Dis 1994; 15: 19S-25S.
21. Jarjour NN, Busse WW. Cytokines in bronchoalveolar lavage fluid of patients with nocturnal asthma. Am J Resp Crit Care Med 1995; 152: 1474-1477.
22. Barnes PJ. Inflammatory mechanisms and nocturnal asthma. Am J Med 1988; 85(Suppl 1B): 64-70.
23. Martin RJ. Nocturnal asthma: structure and function. Chest 1995; 107: S158-S161.
24. Jarjour NN, Sheth KK, Busse WW. Cellular mechanisms of nocturnal asthma: the role of the eosinophil, neutrophil and mast cell. In: Martin RJ, Ed. Nocturnal Asthma: Mechanisms and Treatment. New York: Futura Publishing, 1993; 163-197.
25. Martin RJ. Nocturnal asthma. In: Martin RJ, Ed. Cardiopulmonary Disorders During Sleep. New York: Futura Publishing Co., 1990; 189-214.
26. Barnes P, Fitzgerald G, Brown M, Dollery C. Nocturnal asthma and changes in circulating epinephrine, histamine and Cortisol. N Engl J Med 1980; 303: 263-267.
27. Barnes PJ. Autonomic control of the airways and nocturnal asthma. In: Barnes PJ, Levy J, Eds. Nocturnal Asthma (Symposium 73). Royal Society of Medicine, London, 1984; 69-75.
28. Moore-Ede MC, Czeisler CA, Richardson GS. Circadian time-keeping in health and disease. N Engl J Med 1983; 309: 469-476.
29. Szefler SJ, Ando R, Cicutto LC et al. Plasma histamine, epinephrine, cortisol, and leukocyte β-adrenergic receptors in nocturnal asthma. Clin Pharmacol Ther 1991; 49: 59-68.
30. 2-adrenergic receptor in nocturnal and nonnocturnal asthma: evidence that Gly 16 correlates with the nocturnal phenotype. J Clin Invest 1995; 95: 1635-1641.
31. Reinberg A, Gervais P, Choussade M et al. Circadian changes in effectiveness of corticosteroids in eight patients with allergic asthma. J Allergv Clin Immunol 1983; 71: 425-433.
32. Petroni KC, Shen L, Guyre PM. Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-y and glucocorticosteroids. J Immunol 1988; 140: 3467-3472.
33. Lamas AM, Marcotte GV, Schleimer RP. Human endothelial cells prolong eosinophil survival: regulation by cytokines and glucocorticosteroids. J Immunol 1989; 142: 3978-3984.
34. Schleimer RP. Effect of glucocorticosteroids on inflammatory cells relevant to their therapeutic application of asthma. Am Rev Resp Dis 1990; 141: S59-S69.
35. Barnes PJ. Cholinergic control of airway smooth muscle. Am Rev Resp Dis 1987; 136: 542-545.
36. Widdicombe JG, Karlsson J-A, Barnes PJ. Cholinergic mechanisms in bronchial hyperresponsiveness and asthma. In: Kaliner MA, Barnes PJ, Perssons CGA, Eds. Asthma: its Pathophysiology and Treatment. New York: Marcel Dekker, 1991; 327-356.
37. Baust W, Bohnert B. The regulation of heart rate during sleep. Exp Brain Res 1969; 7: 169-180.
38. Cox ID, Hughes DTD, McConnell K. Ipratropium bromide in patients with nocturnal asthma. Postgrad Med J 1984; 60: 526-528.
39. Gaultier C, Reinberg J, Gerbeaux J et al. Circadian changes in lung resistance and dynamic compliance in healthy and asthmatic children: effects of two bronchodilators. Resp Physiol 1977; 31: 169-182.
40. Widdicombe JG. Reflexes from the upper respiratory tract. In: Cherniack NS, Widdicombe JG, Eds. Handbook of Physiology: the Respiratory System: Control of Breathing. Bethesda, MD: American Physiologial Society, 1986; 363-394.
41. Coe CI, Barnes PJ. Reduction of nocturnal asthma by an inhaled anti-cholinergic drug. Chest 1986; 90: 485-488.
42. Morrison JFJ, Pearson SB, Dean HG. Parasympathetic nervous system in nocturnal asthma. BMJ 1988; 296: 1427-1429.
43. De Vries K, Goei JT, Booy-Noord H, Orie NGM. Changes during 24 hours in lung function and histamine hyperreactivity of the bronchial tree in asthmatics and bronchitic patients. Int Arch Allergy Appl Immunol 1962; 20: 93-101.
44. Bonnet R, Jorres R, Heitman U, Magnussen H. Circadian rhythm in airway responsiveness and airway tone in patients with mild asthma. J Appl Physiol 1992; 71: 1598-1605.
45. Oosterhoff Y, Koëter HG, De Monchy JGR, Postma DS. Circadian variation in airway responsiveness to methacholine, propranolol and AMP in atopic asthmatic subjects. Am Rev Resp Dis 1993; 147: 512-517.
46. Martin RJ, Cicutto LC, Ballard RD. Factors related to nocturnal worsening of asthma. Am Rev Resp Dis 1990; 141: 243-249.
47. Martin RJ, Cicutto LC, Smith HR et al. Airway inflammation in nocturnal asthma. Am Rev Resp Dis 1991; 143: 351-357.
48. Wenzel SE, Martin RJ. The macrophage and lymphocyte in nocturnal asthma: potential role and importance. In: Martin RJ, Ed. Nocturnal Asthma: Mechanisms and Treatment. New York: Futura Publishing, 1993; 199-220.
49. Dahl R. Diurnal variation in the number of circulatory eosinophil leukocytes in normal controls and asthmatics. Acta Allergol 1977; 32: 301-303.
50. Haus E, Lakatua DA, Swoyer J, Sackett-Lundeen L. Chronobiology in hematology and immunology. Am J Anat 1983; 168: 467-517.
51. Calhoun WJ, Bates ME, Schrader L et al. Characteristics of peripheral blood eosinophils in patients with nocturnal asthma. Am Rev Resp Dis 1992; 145: 577-581.
52. Wempe JB, Tammeling EP, Koëter GH et al. Blood eosinophil numbers and activity during 24 hours: effects of treatment with budesonide and bambuterol. J Allergy Clin Immunol 1992; 90: 757-765.
53. Oosterhoff Y, Kauffman HF, Rutgers B et al. Inflammatory cell number and mediators in bronchoalveolar lavage fluid and peripheral blood in subjects with asthma with increased airways narrowing. J Allergy Clin Immunol 1995; 96: 219-229.
54. Walker C, Kaegi MK, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991; 88: 935-942.
55. Arm JP, Lee TH. The pathophysiology of bronchial asthma. Adv Immunol 1992; 51: 323-382.
56. Oosterhoff Y, Hoogsteden HC, Rutgers B et al. Lymphocyte and macrophage activation in bronchoalveolar lavage fluid in nocturnal asthma. Am J Resp Crit Care Med 1995; 151: 75-81.
57. Dunnill M. The pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol 1960; 13: 27-33.
58. Beasley R, Roche W, Roberts J et al. Cellular events in the bronchi in mild asthma after bronchial provocation. Am Rev Resp Dis 1989; 139: 806-817.
59. Azzawi M, Bradley B, Jeffrey K et al. Identification of activated T-lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Reap Dis 1990; 142: 1407-1413.
60. Pincus DJ, Beam WR, Martin RJ. Chronobiology and chronotherapy of asthma. Clin Chest Med 1995; 16: 699-713.
61. Borish L, Mascali JJ, Dishuck J et al. Detection of alveolar macrophage-derived IL-1 beta in asthma: inhibition with corticosteroids. J Immunol 1992; 149: 3078-3082.
62. Plantanias LC, Vogelzang NJ. Interleukin-1: biology, pathophysiology, and clinical prospects. Am J Med 1990; 89: 621-629.
63. Henderson WR. Eicosanoids and platelet-activating factor in allergic respiratory diseases. Am Rev Resp Dis 1991; 143: S86-S90.
64. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990; 323: 645-655.
65. Smith MJH, Ford-Hutchinson AW, Bray MA. Leukotriene B: a potential mediator of inflammation. J Pharmacol 1980; 52: 51-78.
66. 4 in guinea pig isolated perfused lung and parenchymal strips of guinea pig, rabbit and rat. Prostaglandins 1981; 21: 793-803.
67. 4 and histamine in normal human subjects. Thorax 1984; 39: 500-504.
68. Dahlen SE, BjorkT, Hedqvist P et al. Leukotrienes promote plasma leakage and leukocyte adhesion in post-capillary vessels: in vivo effects with relevance to acute inflammatory response. Proc Nat Acad Sci 1981; 78: 3887-3891.
69. 4 on glycoproteins and lysosyme secretion by human bronchial mucosa. Prostaglandins 1983; 25(2): 155-170.
70. 4 in the assessment of nocturnal asthma. J Allergy Clin Immunol 1996; 97: 735-741.
71. Wenzel SE, Trudeau JB, Kaminsky DA et al. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Resp Crit Care Med 1995; 152: 897-905.
72. 2 potentiates airway responsiveness to histamine and methacholine. Am Rev Resp Dis 1986; 133: 252-254.
73. Kraft M, Djukanovic R, Torvik J et al. Evaluation of airway inflammation by endobronchial and transbronchial biopsy in nocturnal and non-nocturnal asthma. Am J Resp Crit Care Med 1994; 144: A955 (abstract).
74. Jarjour NN, Busse WW, Calhoun WJ. Enhanced production of oxygen radicals in nocturnal asthma. Am Rev Resp Dis 1992; 146: 905-911.
75. Pilewski JM, Albelda SM. Cell adhesion molecules in asthma: homing activation and airway remodeling. Am J Resp Cell Mol Biol 1995; 12: 1-3.
76. Casale R, Natali G, Colantonio D, Pasqualetti P. Circadian rhythm to peak expiratory flow in children passively exposed and not exposed to cigarette smoke. Thorax 1992; 47: 801-803.
77. Davies RJ, Hendrick DJ, Pepys J. Asthma due to inhaled chemical agents: ampicillin, benzyl penicillin, 6-amino penicillanic acid and related substances. Clin Allergy 1974; 4: 227-247.
78. Davies RJ, Green M, Schofield NMC. Recurrent nocturnal asthma after exposure to grain dust. Am Rev Resp Dis 1976; 114: 1011-1019.
79. O'Byrne PM, Dolovich J, Hargreave FE. Late asthmatic response. Am Rev Resp Dis 1987; 136: 740-751.
80. Metzger WJ, Richardson HB, Worden K et al. Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation. Chest 1986; 89: 477-483.
81. Newman Taylor AJ, Davies RJ, Hendrick DJ et al. Recurrent nocturnal asthma reacting to bronchial provocation tests. Clin Allergy 1979; 9: 213-219.
82. Mohiuddin AA, Martin RJ. Circadian basis of the late asthmatic response. Am Rev Resp Dis 1990; 142: 1153-1157.
83. Cockcroft DW. Mechanism of perennial allergic asthma. Lancet 1983; 2: 253-256.
84. Durham SR. Late asthmatic responses. Resp Med 1990; 84: 263-268.
85. Sullivan CE, Murphy E, Kazan LF et al. Waking and ventilatory responses to laryngeal stimulation in sleeping dogs. J Appl Physiol 1978; 45: 681-689.
86. Ballard RJD, Saathoff MC, Patel DK et al. Effect of sleep on nocturnal bronchoconstriction and ventilatory patterns in asthmatics. J Appl Physiol 1989; 67: 243-249.
87. Catterall JR, Douglas NJ, Calverley PMA. Irregular breathing and hypoxaemia during sleep in chronic stable asthma. Lancet 1982; i: 301-314.
88. Clark TH, Herzel M. Diurnal variation of asthma. Br J Dis Chest 1977; 71: 87-92.
89. Chan CS, Woolcock AJ, Sullivan CE. Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Resp Dis 1988; 137: 1502-1504.
90. Guilleminault C, Winkle R, Melvin K, Tilkian A. Cyclic variation of the heart rate in sleep apnoea syndrome, mechanisms and usefulness of 24-hour electrocardiography as a screening technique. Lancet 1984; 1: 126-136.
91. Overholt RH, Voorhees RJ. Esophageal reflux as a trigger in asthma. Dis Chest 1966; 49: 464-466.
92. Urschel HC Jr, Paulson DL. Gastroesophageal reflux and hiatal hernia: complications and therapy. J Thorac Cardiovasc Surg 1967; 53: 32-37.
93. Davis MV. Evolving concepts regarding hiatus hernia and gastroesophageal reflux. Ann Thorac Surg 1969; 7: 120-133.
94. Mays EE. Intrinsic asthma in adults: association with gastroesophageal reflux. JAMA 1976; 236: 2626-2628.
95. Bellia V, Visconti A, Cuttitta G et al. Gastroesophageal reflux and nocturnal asthma. Prog Resp Res 1990; 24: 179-184.
96. Herve P. Denjean A, Jian R et al. Intraesophageal perfusion of acid increases the bronchomotor response to methacholine and to isocapnic hyperventilation in asthmatic subjects. Am Rev Resp Dis 1986; 139: 986-989.
97. Goodall RJR, Earis JE, Cooper DW et al. Relationship between asthma and gastro-oesophageal reflux. Thorax 1981; 36: 116-121.
98. Chen WY, Horton DJ, Weiser PC. Airway obstruction induced by body cooling in asthmatics. Physiologist 1977; 20: 16.
99. Chen WY, Horton DJ. Airway obstruction in asthmatics induced by body cooling. Scand J Resp Dis 1978; 59: 13-20.
100. Horton DJ, Chen WY. Effect of breathing warm humidified air on bronchoconstriction induced by cooling and by inhalation of methacholine. Chest 1979; 75: 24-28.
101. Chen WY, Chai H. Airway cooling and nocturnal asthma. Chest 1982; 81: 675-680.
102. Hetzel MR, Clark TJH. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 1980; 35: 732-738.
103. 2-agonists. Drugs 1994; 47: 207-222.
104. Nelson HS. β-adrenergic bronchodilator. N Engl J Med 1995; 333: 499-506.
105. Barnes PJ, Adcock IM. Anti-inflammatory action of steroids: molecular mechanisms. Trends Pharmacol Sci 1993; 14: 436-441.
106. Beam WR, Weiner DE, Martin RJ. Timing of prednisolone and alteration of airway inflammation in nocturnal asthma. Am Rev Resp Dis 1992; 146: 1524-1530.
107. Reinberg A. Chronopharmacology of corticosteroids and ACTH. In: Lemmer B, Ed. Chronopharmacology: Cellular and Biochemical Interactions. New York: Marcel Dekker, 1989; 137-167.
108. British Thoracic Society, British Paediatric Association, Research Unit of the Royal College of Physicians, King's Fund Centre, National Asthma Campaign, Royal College of General Practitioners et al. Guidelines for management of asthma in adults. 1. Chronic persistent asthma. Thorax 1993; 48(Suppl): S1-S24.
109. D'Alonzo GE, Smolensky MH, Feldman S et al. Twenty-four hour lung function in adult patients with asthma: chronoptimized theophylline once daily in the evening versus conventional twice-daily dosing. Am Rev Resp Dis 1990; 142: 84-90.
110. Martin R, Cicutto L, Ballard R et al. Circadian variation in theophylline concentrations and the treatment of nocturnal asthma. Am Rev Resp Dis 1989; 139: 475-478.
111. Zwillich CW, Neagley SR, Cicutto L et al. Nocturnal asthma therapy: inhaled bitolterol versus sustained-release theophylline. Am Rev Resp Dis 1989; 139: 470-474.
112. Barnes NC, Kurteit LM. Drugs affecting the leukotriene pathway in asthma. Br J Clin Pract 1995; 49: 262-266.
113. Israel E, Rubin P, Kemp JP et al. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann Intern Med 1993; 119: 1059-1066.
114. 4-induced bronchoconstriction in subjects with bronchial asthma: a concentration-effect studv of ICI 204, 219. Clin Pharmacol Ther 1993; 54: 430-436.
115. 4 receptor antagonist, in subjects with bronchial asthma. Am J Resp Crit Care Med 1994; 150: 618-623.